Истраживачи
Spasić, Jelena
Results 1-20 of 54
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2024 | IGF-1R, E-cadherin, N-cadherin, and occludin gene expression and resistance to EGFR tyrosine-kinase inhibitors in patients with lung adenocarcinoma in Serbia![]() | Jokić, Vera M.; Čavić, Milena R. | Conference Paper | Mp. category will be shown later |
| 2024 | Abstract 1304: Employing widening funds to address inequity in cancer research - example of the STEPUPIORS collaborative rectal cancer project![]() | Cavic, Milena | Conference Paper | Mp. category will be shown later |
| 2024 | Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy![]() | Stanojevic, Aleksandra | Article | 21M21 |
| 2024 | Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia – Insights from the Institute for Oncology and Radiology of Serbia![]() | Cavic, Milena | Other | Mp. category will be shown later |
| 2024 | Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia—Insights from the Institute for Oncology and Radiology of Serbia![]() | Cavic, Milena | Article | 21M21 |
| 2024 | Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer.![]() | Vuletić, Ana | Article | 21aM21a |
| 2023 | L14 Establishment of a first cancer Biobank at the Institute for Oncology and Radiology of Serbia – advantages, challenges and future perspectives![]() | Bjelogrlić, Snežana K. | Conference Paper | Mp. category will be shown later |
| 2023 | Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab![]() | Homšek Ana | Article | 22M22 |
| 2023 | Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology![]() | Homšek, Ana | Article | 23M23 |
| 2023 | Methylenetetrahydrofolate reductase polymorphic variants in rectal cancer: significance for cancer risk and response to chemoradiotherapy![]() | Stanojevic, Aleksandra | Other | Mp. category will be shown later |
| 2023 | Circulating cell-free DNA fragmentation profiles during systemic therapy of advanced-stage non-small cell lung cancer patients![]() | Milovanovic, Jelena. | Conference Paper | Mp. category will be shown later |
| 2023 | Ultra-short cfDNA fragment detection during systemic therapy of advanced-stage colorectal cancer![]() | Milovanović, Jelena | Conference Paper | Mp. category will be shown later |
| 2022 | Case report: Acute toxic myocardial damage caused by 5-fluorouracil-from enigma to success![]() | Lasica, Ratko | Article | 21M21 |
| 2022 | Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma![]() | Jokic, Vera M; Savic-Vujovic, Katarina R | Article | 22M22 |
| 2022 | Lung Cancer in Serbia![]() | Čavić Milena | Article | 21a+M21a+ |
| 2022 | Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer![]() | Spasić, Jelena | Article | 22M22 |
| 2021 | Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity![]() | Jokić, Vera; Savić-Vujović, Katarina | Article | 22M22 |
| 2021 | The Value of Clinical and Genetic Factors in Pain Management in EGFR Mutated Advanced Lung Adenocarcinoma Patients![]() | Cavic, Milena R | Conference Paper | Mp. category will be shown later |
| 2021 | The value of Th2-related thymic stromal lymphopoietin as a prognostic and predictive biomarker in non-small cell lung cancer![]() | Cavic, Milena R | Conference Paper | Mp. category will be shown later |
| 2021 | Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients![]() | Nikolic Neda | Article | 21M21 |
